|
JPS5824085B2
(ja)
|
1978-02-28 |
1983-05-19 |
井関農機株式会社 |
コンバイン用カッタ−
|
|
JPS561156A
(en)
|
1979-06-15 |
1981-01-08 |
Matsushita Electric Works Ltd |
Grounding tool for negative potential treating appliance
|
|
IT1195304B
(it)
|
1981-12-22 |
1988-10-12 |
Anic Spa |
Metodo per la preparazione di gem-diammino derivati n-monoacilati
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US4698327A
(en)
|
1985-04-25 |
1987-10-06 |
Eli Lilly And Company |
Novel glycopeptide derivatives
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
IT1190389B
(it)
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
IT1227907B
(it)
|
1988-12-23 |
1991-05-14 |
Eniricerche S P A Milano Sclav |
Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
|
|
JP2752788B2
(ja)
|
1989-01-23 |
1998-05-18 |
カイロン コーポレイション |
感染および過剰増殖障害の為の組換え療法
|
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
AU1753892A
(en)
|
1991-04-10 |
1992-11-17 |
General Hospital Corporation, The |
Mammalian gap-43 compositions and methods of use
|
|
US5350835A
(en)
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
|
US5994108A
(en)
|
1991-11-05 |
1999-11-30 |
Board Of Regents, The University Of Texas System |
Mutant TAR virus and transdominant tat mutants as pharmacological agents
|
|
JPH07505283A
(ja)
|
1992-03-20 |
1995-06-15 |
ベイラー・カレッジ・オブ・メディシン |
Ｄｎａトランスポーター系および使用方法
|
|
WO1993019768A1
(en)
|
1992-04-03 |
1993-10-14 |
The Regents Of The University Of California |
Self-assembling polynucleotide delivery system
|
|
WO1994004562A1
(en)
|
1992-08-13 |
1994-03-03 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
|
EP0656950B1
(en)
|
1992-08-21 |
1998-11-04 |
Biogen, Inc. |
Tat-derived transport polypeptides
|
|
AU667578B2
(en)
|
1992-08-27 |
1996-03-28 |
Deakin Research Limited |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
|
US5545551A
(en)
|
1992-08-28 |
1996-08-13 |
Mt. Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of pur protein
|
|
KR950703640A
(ko)
|
1992-10-09 |
1995-09-20 |
가일 케이,나우톤. |
간 보존 세포(liver reserve cells)
|
|
WO1994023751A1
(de)
|
1993-04-14 |
1994-10-27 |
Boehringer Mannheim Gmbh |
Nukleinsäure-transferpeptide und deren verwendung zur einschleusung von nukleinsäuren in eukaryontische zellen
|
|
EP0679716A4
(en)
|
1993-11-12 |
1999-06-09 |
Kenichi Matsubara |
GENE SIGNATURE.
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
JPH10508205A
(ja)
|
1995-04-25 |
1998-08-18 |
バクスター インターナショナル インコーポレイテッド |
肝細胞および膵臓ランゲルハンス島細胞を単離するためのコラーゲナーゼおよびキモパパインを含有する組成物
|
|
BR9610058A
(pt)
|
1995-07-28 |
1999-07-27 |
Marie Curie Cancer Care |
Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
|
|
WO1997010836A1
(en)
|
1995-09-21 |
1997-03-27 |
Innapharma, Inc. |
Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
|
|
IE80466B1
(en)
|
1995-11-10 |
1998-07-29 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
US5877282A
(en)
|
1996-09-20 |
1999-03-02 |
Bristol-Myers Squibb Company |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
|
|
US6187817B1
(en)
|
1996-10-03 |
2001-02-13 |
Southern Illinois University School Of Medicine |
Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
|
|
US6361938B1
(en)
|
1996-11-08 |
2002-03-26 |
Elan Corporation, Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
WO1998023781A1
(en)
|
1996-11-26 |
1998-06-04 |
Johns Hopkins University |
Ligand detection system and methods of use thereof
|
|
US5989814A
(en)
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
|
US5880261A
(en)
|
1997-04-03 |
1999-03-09 |
Waeber; Gerard |
Transcription factor Islet-Brain 1 (IB1)
|
|
AU6972798A
(en)
|
1997-04-18 |
1998-11-13 |
University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
|
US6043083A
(en)
|
1997-04-28 |
2000-03-28 |
Davis; Roger J. |
Inhibitors of the JNK signal transduction pathway and methods of use
|
|
CA2290756A1
(en)
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
|
US20040152084A1
(en)
|
2003-01-31 |
2004-08-05 |
Slattum Paul M. |
Compounds and processes for single-pot attachment of a label to nucleic acid
|
|
KR20010012809A
(ko)
|
1997-05-21 |
2001-02-26 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
생체막을 통한 수송을 증진시키는 조성물 및 방법
|
|
FR2767323B1
(fr)
|
1997-08-12 |
2001-01-05 |
Synt Em |
Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
|
|
EP0897002A3
(en)
|
1997-08-14 |
2001-10-04 |
Smithkline Beecham Plc |
U62317, a protein having a JNK-binding domain
|
|
AU9402898A
(en)
|
1997-09-26 |
1999-04-23 |
Washington University |
Cell death agonists
|
|
US6420031B1
(en)
|
1997-11-03 |
2002-07-16 |
The Trustees Of Princeton University |
Highly transparent non-metallic cathodes
|
|
HUP0100348A3
(en)
|
1997-10-20 |
2002-12-28 |
Hoffmann La Roche |
Bicycles containing a six menbered ring with one or two nitrogen atoms, process for their preparation, use of them, pharmaceutical compositions containing the same and intermediates
|
|
US6270956B1
(en)
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
|
EP0947524A1
(en)
|
1998-03-30 |
1999-10-06 |
Upither B.V. |
Novel peptides for the treatment of autoimmune diseases
|
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
|
WO1999055682A1
(en)
|
1998-04-29 |
1999-11-04 |
Georgetown University |
Methods of identifying and using hla binding compounds as hla-agonists and antagonists
|
|
EP1076711A2
(en)
|
1998-05-13 |
2001-02-21 |
Incyte Pharmaceuticals, Inc. |
Human apoptosis associated proteins
|
|
US6811992B1
(en)
|
1998-05-14 |
2004-11-02 |
Ya Fang Liu |
Method for identifying MLK inhibitors for the treatment of neurological conditions
|
|
AU3714499A
(en)
|
1998-05-14 |
1999-11-29 |
Pasteur Merieux Serums Et Vaccins |
Hepatitis c virus mimotopes
|
|
WO1999066061A1
(en)
|
1998-06-18 |
1999-12-23 |
Dnavec Research, Inc. |
Nucleic acid transfer phage
|
|
CA2328457A1
(en)
|
1998-06-20 |
1999-12-29 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
|
US6552167B1
(en)
|
1998-08-28 |
2003-04-22 |
Gryphon Therapeutics, Inc. |
Polyamide chains of precise length
|
|
ES2288042T3
(es)
|
1998-09-25 |
2007-12-16 |
Cephalon, Inc. |
Uso de pirrolocarbazoles condensados para prevenir/tratar daños de las celulas ciliadas sensoriales y neuronas cocleares.
|
|
US20020090696A1
(en)
|
1998-12-08 |
2002-07-11 |
Miller Carol A. |
Treating neurological disorders using human apoptosis inhibiting protein
|
|
US6656474B1
(en)
|
1999-01-15 |
2003-12-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
|
|
US6673908B1
(en)
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
|
AU765983B2
(en)
|
1999-05-28 |
2003-10-09 |
Apoptosis Technology, Inc. |
Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
|
|
US7510824B2
(en)
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
|
WO2000075118A1
(en)
|
1999-06-03 |
2000-12-14 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
|
|
DK1102785T3
(da)
|
1999-06-07 |
2013-05-13 |
Arrowhead Res Corp |
Sammensætninger til lægemiddeltilførsel ved anvendelse af pH-følsomme molekyler
|
|
US6593292B1
(en)
|
1999-08-24 |
2003-07-15 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
AU7473500A
(en)
|
1999-09-01 |
2001-03-26 |
University Of Pittsburgh |
Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses
|
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20030108539A1
(en)
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
JP2003523323A
(ja)
|
1999-12-06 |
2003-08-05 |
ザ ジェネラル ホスピタル コーポレーション |
膵臓幹細胞および移植におけるその使用
|
|
EP2140881B1
(en)
|
1999-12-16 |
2013-04-17 |
Biogen Idec MA Inc. |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
CA2410224C
(en)
|
2000-06-16 |
2013-08-13 |
Zealand Pharma A/S |
Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
|
|
US6586403B1
(en)
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
|
CA2425610A1
(en)
|
2000-10-13 |
2002-04-18 |
University Of Lausanne |
Intracellular delivery of biological effectors by novel transporter peptide sequences
|
|
US7033597B2
(en)
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
|
AU1112202A
(en)
|
2000-10-17 |
2002-04-29 |
Diatranz Ltd |
Preparation and xenotransplantation or porcine islets
|
|
CA2437248A1
(en)
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
|
US20030077826A1
(en)
|
2001-02-02 |
2003-04-24 |
Lena Edelman |
Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
|
|
AU2002240312A1
(en)
|
2001-02-08 |
2002-08-19 |
Pankaj Paranjp |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
|
JP2005508832A
(ja)
|
2001-02-16 |
2005-04-07 |
セルゲイト， インコーポレイテッド |
間隔を開けてアルギニン部分を含むトランスポーター
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
US6653443B2
(en)
|
2001-04-06 |
2003-11-25 |
Thomas Jefferson University |
Multimerization of HIV-1 Vif protein as a therapeutic target
|
|
US20060216706A1
(en)
|
2001-07-17 |
2006-09-28 |
Tang Y T |
Proteins associated with cell growth, differentiation, and death
|
|
WO2004045535A2
(en)
|
2002-11-14 |
2004-06-03 |
Arbor Vita Corporation |
Molecular interactions in neurons
|
|
DE60230890D1
(de)
|
2001-09-19 |
2009-03-05 |
Aventis Pharma Sa |
Indolizine als kinaseproteinhemmer
|
|
GB0129044D0
(en)
|
2001-12-05 |
2002-01-23 |
Koninkl Philips Electronics Nv |
Data storage methods and apparatuses with basic and extended file system capacity
|
|
JP2005525096A
(ja)
|
2002-01-09 |
2005-08-25 |
ユニバーシティ オブ ローザンヌ |
Ｊｎｋシグナル伝達経路の細胞浸透性ペプチドインヒビター
|
|
JP2005533748A
(ja)
|
2002-03-08 |
2005-11-10 |
シグナル ファーマシューティカルズ，インコーポレイテッド |
増殖性障害および癌を治療、予防、または管理するための併用療法
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
JP2004066595A
(ja)
|
2002-08-05 |
2004-03-04 |
Canon Finetech Inc |
記録装置およびレジストレーション用パターンの記録方法
|
|
JP2006516383A
(ja)
|
2002-09-09 |
2006-07-06 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
Ｂｈ３ペプチドおよびその使用方法
|
|
PL374700A1
(pl)
|
2002-09-20 |
2005-10-31 |
Alcon, Inc. |
Zastosowanie inhibitorów syntezy cytokiny do leczenia zespołu suchego oka
|
|
DE50209178D1
(de)
|
2002-10-11 |
2007-02-15 |
Imvision Gmbh |
Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen
|
|
WO2004037196A2
(en)
|
2002-10-24 |
2004-05-06 |
Sangstat Medical Corporation |
Cytomodulating peptides and methods for treating neurological disorders
|
|
MXPA05005101A
(es)
|
2002-11-15 |
2005-09-08 |
Sangstat Medical Corp |
Peptidos de citomodulacion para el tratamiento de cistitis intersticial.
|
|
NZ540546A
(en)
|
2002-11-18 |
2008-03-28 |
Celgene Corp |
Methods of using and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
US7166692B2
(en)
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
|
WO2004092339A2
(en)
|
2003-04-11 |
2004-10-28 |
Ilex Products, Inc. |
Modulation of muc1 mediated signal transduction
|
|
ES2351976T3
(es)
|
2003-04-29 |
2011-02-14 |
Avi Biopharma, Inc. |
Composiciones para mejorar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células.
|
|
AU2004316996A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
US20050048995A1
(en)
|
2003-08-25 |
2005-03-03 |
Motorola, Inc. |
System and method for controlling the operating characteristics of a buffer
|
|
KR100685345B1
(ko)
|
2004-03-27 |
2007-02-22 |
학교법인조선대학교 |
세포사 유도 펩타이드
|
|
KR20060134198A
(ko)
|
2004-04-08 |
2006-12-27 |
어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. |
Ｊｎｋ 저해제 및 시클로스포린을 포함하는 조성물
|
|
JP2008510766A
(ja)
|
2004-08-27 |
2008-04-10 |
ゲーペーツェー ビオテック アーゲー |
ピリミジン誘導体
|
|
US7286835B1
(en)
|
2004-09-10 |
2007-10-23 |
Airespace, Inc. |
Enhanced wireless node location using differential signal strength metric
|
|
US20060094753A1
(en)
|
2004-10-29 |
2006-05-04 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
|
|
EP1656951A1
(en)
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Conjugates with enhanced cell uptake activity
|
|
US20100256041A1
(en)
|
2004-11-12 |
2010-10-07 |
Christophe Bonny |
Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
|
|
EP1661912A1
(en)
|
2004-11-29 |
2006-05-31 |
Xigen S.A. |
Fusion protein comprising a BH3-domain of a BH3-only protein
|
|
EP1676574A3
(en)
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Methods for promoting survival of transplanted tissues and cells
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
CN101208333A
(zh)
|
2005-04-29 |
2008-06-25 |
细胞基因公司 |
1-(5-(1h-1,2,4-三唑-5-基)(1h-吲唑-3-基))-3-(2-哌啶基乙氧基)苯的固体形式
|
|
US20070015779A1
(en)
|
2005-04-29 |
2007-01-18 |
John Griffin |
Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
US8080517B2
(en)
*
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
WO2008006046A1
(en)
*
|
2006-07-06 |
2008-01-10 |
Case Western Reserve University |
Ceramide composition and use thereof in treatment of ocular diseases
|
|
EP1884521A1
(en)
|
2006-07-31 |
2008-02-06 |
Xigen S.A. |
Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
|
|
US20080051410A1
(en)
|
2006-08-02 |
2008-02-28 |
Northwestern University |
Protein Kinase Targeted Therapeutics
|
|
CN101511359B
(zh)
|
2006-09-08 |
2012-09-05 |
霍夫曼-拉罗奇有限公司 |
苯并三唑激酶调节剂
|
|
CA2663545A1
(en)
|
2006-09-19 |
2008-03-27 |
Phylogica Limited |
Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
|
|
GB0702259D0
(en)
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
BRPI0911518A2
(pt)
|
2008-04-29 |
2017-06-13 |
Pharnext |
novas aproximações terapêuticas para o tratamento da doença de alzheimer e doenças relacionadas através de uma modulação de resposta ao estresse de célula
|
|
EP2285364B1
(en)
|
2008-05-07 |
2015-01-21 |
The Regents of The University of California |
Therapeutic replenishment and enrichment of ocular surface lubrication
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
US20100183633A1
(en)
|
2008-12-04 |
2010-07-22 |
University Of Massachusetts |
Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
|
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
EP2381934A2
(en)
|
2008-12-23 |
2011-11-02 |
Carmel - Haifa University Economic Corp Ltd. |
Improving cognitive function
|
|
WO2010091310A1
(en)
|
2009-02-06 |
2010-08-12 |
Elan Pharmaceuticals, Inc. |
Inhibitors of jun n-terminal kinase
|
|
EA201171188A1
(ru)
*
|
2009-03-30 |
2012-05-30 |
Сантен Фармасьютикал Ко., Лтд. |
Профилактическое или терапевтическое средство против болезни сетчатки и способ профилактики или лечения болезни сетчатки с использованием jnk (c-jun-аминоконцевая киназа)-ингибиторного пептида, а также применение указанного пептида
|
|
EP2490698A4
(en)
|
2009-10-22 |
2013-09-25 |
Hoffmann La Roche |
MODULATION OF AXONES DEGENERATION
|
|
US20130190244A1
(en)
|
2009-12-31 |
2013-07-25 |
Stealth Peptides International, Inc. |
Methods for performing a coronary artery bypass graft procedure
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
AU2010362444B2
(en)
|
2010-10-14 |
2015-08-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
DK2902035T3
(en)
|
2010-10-14 |
2018-09-24 |
Xigen Inflammation Ltd |
METHODS FOR TREATING MUSCLE DYROPHY
|
|
US8471027B2
(en)
|
2011-04-06 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Adamantyl compounds
|
|
MX2014006399A
(es)
|
2011-11-30 |
2015-04-10 |
Xigen Inflammation Ltd |
Uso de inhibidores de peptidos con celulas permeables de la via para transduccion de señal de jnk para el tratamiento de la queratoconjuntivitis seca.
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
WO2016207413A1
(en)
|
2015-06-26 |
2016-12-29 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of mild cognitive impairment
|
|
WO2015197193A2
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
WO2014206426A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
AU2014301631A1
(en)
|
2013-06-26 |
2015-08-27 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
|
|
JP2015197193A
(ja)
|
2014-04-02 |
2015-11-09 |
トヨタ自動車株式会社 |
車両用無段変速機の油圧制御装置
|